<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">606176012</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20210128100745.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">210128e20150201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s00018-014-1694-0</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s00018-014-1694-0</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Satya Kolar, Vincenzo Luca, Hasna Baidouri, Giuseppe Mannino, Alison McDermott, Maria Mangoni]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Pseudomonas aeruginosa is the primary bacterial pathogen causing contact lens related keratitis. Available ophthalmic agents have reduced efficacy and antimicrobial peptides (AMPs) hold promise as future antibiotics. Here we investigated the in vitro and in vivo anti-Pseudomonal activity of esculentin-1a(1-21)NH2, derived from a frog skin AMP. The data revealed a minimum inhibitory concentration between 2 and 16μM against reference strains or drug-resistant clinical isolates of P. aeruginosa without showing toxicity to human corneal epithelial cells up to 50μM. At 1μM the peptide rapidly killed bacterial cells and this activity was fully retained in 150mM sodium chloride and 70% (v/v) human basal tears, particularly against the virulent ATCC 19660 strain. Furthermore, its dropwise administration at 40μM to the ocular surface in a murine model of P. aeruginosa keratitis (three times daily, for 5days post-infection) resulted in a significant reduction of infection. The mean clinical score was 2.89±0.26 compared to 3.92±0.08 for the vehicle control. In addition, the corneal level of viable bacteria in the peptide treated animals was significantly lower with a difference of 4 log10 colony counts, compared to 7.7 log10 cells recovered in the control. In parallel, recruitment of inflammatory cells was reduced by half compared to that found in the untreated eyes. Similar results were obtained when esculentin-1a(1-21)NH2 was applied prior to induction of keratitis. Overall, our findings highlight esculentin-1a(1-21)NH2 as an attractive candidate for the development of novel topical pharmaceuticals against Pseudomonas keratitis.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Basel, 2014</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Innate immunity</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Ocular surface infections</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Antibiotic resistance</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Amphibian skin antimicrobial peptides</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">AMP : Antimicrobial peptide</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">BAC : Benzalkonium chloride</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">CFU : Colony-forming units</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Esc-1a(1-21)NH2 : Esculentin-1a(1-21)NH2</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">hTCEpi : Telomerase-immortalized human cornel epithelial cells</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">LB : Luria-Bertani</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">MH : Mueller-Hinton</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">MIC : Minimal inhibitory concentration</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">MTT : 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">MPO : Myeloperoxidase</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">PB : Phosphate buffer</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">PBS : Phosphate buffered saline</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kolar</subfield>
   <subfield code="D">Satya</subfield>
   <subfield code="u">College of Optometry, The Ocular Surface Institute, University of Houston, Houston, TX, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Luca</subfield>
   <subfield code="D">Vincenzo</subfield>
   <subfield code="u">Department of Biochemical Sciences &quot;A. Rossi Fanelli”, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Via degli Apuli 9, 00185, Rome, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Baidouri</subfield>
   <subfield code="D">Hasna</subfield>
   <subfield code="u">College of Optometry, The Ocular Surface Institute, University of Houston, Houston, TX, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Mannino</subfield>
   <subfield code="D">Giuseppe</subfield>
   <subfield code="u">Ophthalmology Unit, NESMOS Department, S. Andrea Hospital, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">McDermott</subfield>
   <subfield code="D">Alison</subfield>
   <subfield code="u">College of Optometry, The Ocular Surface Institute, University of Houston, Houston, TX, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Mangoni</subfield>
   <subfield code="D">Maria</subfield>
   <subfield code="u">Department of Biochemical Sciences &quot;A. Rossi Fanelli”, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Via degli Apuli 9, 00185, Rome, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Cellular and Molecular Life Sciences</subfield>
   <subfield code="d">Springer Basel</subfield>
   <subfield code="g">72/3(2015-02-01), 617-627</subfield>
   <subfield code="x">1420-682X</subfield>
   <subfield code="q">72:3&lt;617</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">72</subfield>
   <subfield code="o">18</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s00018-014-1694-0</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s00018-014-1694-0</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kolar</subfield>
   <subfield code="D">Satya</subfield>
   <subfield code="u">College of Optometry, The Ocular Surface Institute, University of Houston, Houston, TX, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Luca</subfield>
   <subfield code="D">Vincenzo</subfield>
   <subfield code="u">Department of Biochemical Sciences &quot;A. Rossi Fanelli”, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Via degli Apuli 9, 00185, Rome, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Baidouri</subfield>
   <subfield code="D">Hasna</subfield>
   <subfield code="u">College of Optometry, The Ocular Surface Institute, University of Houston, Houston, TX, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Mannino</subfield>
   <subfield code="D">Giuseppe</subfield>
   <subfield code="u">Ophthalmology Unit, NESMOS Department, S. Andrea Hospital, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">McDermott</subfield>
   <subfield code="D">Alison</subfield>
   <subfield code="u">College of Optometry, The Ocular Surface Institute, University of Houston, Houston, TX, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Mangoni</subfield>
   <subfield code="D">Maria</subfield>
   <subfield code="u">Department of Biochemical Sciences &quot;A. Rossi Fanelli”, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Via degli Apuli 9, 00185, Rome, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Cellular and Molecular Life Sciences</subfield>
   <subfield code="d">Springer Basel</subfield>
   <subfield code="g">72/3(2015-02-01), 617-627</subfield>
   <subfield code="x">1420-682X</subfield>
   <subfield code="q">72:3&lt;617</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">72</subfield>
   <subfield code="o">18</subfield>
  </datafield>
 </record>
</collection>
